Figure 5.

Effects of integrin β1 (ITGB1) inhibition and bevacizumab treatment on ovarian cancer cell invasion, as determined by wound healing assay. A wound was introduced by scraping a pipette tip across confluent HO-8910 and HO-8910PM cells. After 24 and 48 h, images of the cells were captured under phase-contrast microscopy (magnification, x40). Data are presented as the mean ± standard deviation of duplicates from a representative experiment performed in triplicate. ^*P<0.05, vs. the control (Con) and lentiviral vector (LV)-negative control (NC) groups.